Author: National Cancer Institute (U.S.)
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 78
Book Description
Cancer Progress Report, 2001
Author: National Cancer Institute (U.S.)
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 78
Book Description
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 78
Book Description
Cancer Progress Report Highlights, 2001
Author: National Cancer Institute (U.S.)
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 11
Book Description
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 11
Book Description
Cancer Progress Report, 2001
Author: Richard D. Klausner, M.D.
Publisher:
ISBN: 9780756726553
Category : Medical
Languages : en
Pages : 74
Book Description
Tracks progress, or lack of it, across the full cancer continuum -- from prevention & early detection to diagnosis, treatment, life after cancer, & the end of life. Compares this progress with the cancer-related targets set forth in Healthy People 2010, the nat. set of health objectives for the first decade of the 21st cent. Overall, we are making progress against cancer, & the rates of both new cancers & deaths from cancer have fallen. There are declines in certain behaviors that cause cancer, esp. cigarette smoking by adults, more people are getting screened for breast, cervical, & colorectal cancers, & more practitioners are adopting state-of-the art cancer treat. But the rates of some cancers, such as melanoma skin cancer, are rising. Charts & tables.
Publisher:
ISBN: 9780756726553
Category : Medical
Languages : en
Pages : 74
Book Description
Tracks progress, or lack of it, across the full cancer continuum -- from prevention & early detection to diagnosis, treatment, life after cancer, & the end of life. Compares this progress with the cancer-related targets set forth in Healthy People 2010, the nat. set of health objectives for the first decade of the 21st cent. Overall, we are making progress against cancer, & the rates of both new cancers & deaths from cancer have fallen. There are declines in certain behaviors that cause cancer, esp. cigarette smoking by adults, more people are getting screened for breast, cervical, & colorectal cancers, & more practitioners are adopting state-of-the art cancer treat. But the rates of some cancers, such as melanoma skin cancer, are rising. Charts & tables.
Cancer Progress Report, 2001
Author: National Cancer Institute (U.S.)
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 88
Book Description
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 88
Book Description
Cancer Progress Report Highlights, 2001
Author: National Cancer Institute (U.S.)
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 14
Book Description
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 14
Book Description
Cancer Progress Report, Highlights 2001
Cancer Progress Report
Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations for 2005
Author: United States. Congress. House. Committee on Appropriations. Subcommittee on the Departments of Labor, Health and Human Services, Education, and Related Agencies
Publisher:
ISBN:
Category : United States
Languages : en
Pages : 1890
Book Description
Publisher:
ISBN:
Category : United States
Languages : en
Pages : 1890
Book Description
Monthly Catalog of United States Government Publications
Author:
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 512
Book Description
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 512
Book Description
Proteomics in Diagnostics
Author: T.D. Veenstra
Publisher: IOS Press
ISBN: 9781586034344
Category : Diagnosis
Languages : en
Pages : 88
Book Description
For many diseases, such as heart disease and cancer, early detection plays a pivotal role in the survival rate of the patient. When detected early, many such lethal diseases can be effectively treated with existing remedies. The difficulty remains, however, how to effectively detect such conditions at the earliest possible stage with a high enough positive predictive value so that they can be treated effectively without overwhelming the medical system with false positive diagnoses. What is required is the identification of more effective or additional biomarkers, as well as other types of technologies, that can aid in the diagnosis of early stage diseases. The challenge is how to identify more effective biomarkers or technologies that can provide an earlier indication of a disease with a higher positive predictive value than presently utilized methods. Proteomics, along with genomics and transcriptomics, has benefited greatly from the development of high-throughput methods to study thousands of proteins almost simultaneously.Based on the rate of interesting leads already being discovered using proteomics, it is likely that not only will biomarkers with better sensitivity and specificity be identified but individuals will be treated using customized therapies based on their specific protein profile. Since many of the proteomic technologies and data management tools are still in their infancy, the future of proteomics in disease diagnostics looks extremely promising.
Publisher: IOS Press
ISBN: 9781586034344
Category : Diagnosis
Languages : en
Pages : 88
Book Description
For many diseases, such as heart disease and cancer, early detection plays a pivotal role in the survival rate of the patient. When detected early, many such lethal diseases can be effectively treated with existing remedies. The difficulty remains, however, how to effectively detect such conditions at the earliest possible stage with a high enough positive predictive value so that they can be treated effectively without overwhelming the medical system with false positive diagnoses. What is required is the identification of more effective or additional biomarkers, as well as other types of technologies, that can aid in the diagnosis of early stage diseases. The challenge is how to identify more effective biomarkers or technologies that can provide an earlier indication of a disease with a higher positive predictive value than presently utilized methods. Proteomics, along with genomics and transcriptomics, has benefited greatly from the development of high-throughput methods to study thousands of proteins almost simultaneously.Based on the rate of interesting leads already being discovered using proteomics, it is likely that not only will biomarkers with better sensitivity and specificity be identified but individuals will be treated using customized therapies based on their specific protein profile. Since many of the proteomic technologies and data management tools are still in their infancy, the future of proteomics in disease diagnostics looks extremely promising.